Breast Cancer: Clinical Trials & Research

You may be offered the opportunity to take part in a clinical trial at some point during your treatment for breast cancer. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies hat are not yet readily available.

Sometimes we use clinical trials to compare diagnostic tests, prevention strategies, or other aspects of care.

Showing 51 - 68 of 68 trials
Title Investigatorsort icon
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura, MD
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura, MD
Two Studies of GDC-0032: A Phase I Study of GDC-0032 for Solid Tumors with Increased PI3K Activity, and a Phase II Study of GDC-0032 with Fulvestrant in Patients with Advanced Breast Cancer
[Protocol 13-149]
Dickler, Maura, MD
A Pilot Study of Yoga Practice for Breast or Ovarian Cancer Survivors
[Protocol 14-059]
Deng, Gary, MD, PhD
A Phase II Study of Trastuzumab Emtansine versus Trastuzumab/Paclitaxel in Women with Stage I HER2-Positive Breast Cancer
[Protocol 14-221]
Dang, Chau, MD
A Phase II Study of Gemcitabine plus HER2-Targeting Therapies in Women with Persistent HER2-Positive Advanced Breast Cancer
[Protocol 14-124]
Dang, Chau, MD
A Phase II Study of Pertuzumab and Trastuzumab with Standard Chemotherapy Given Before Surgery in Patients with Locally Advanced, Inflammatory, and Early-Stage HER2-Positive Breast Cancers
[Protocol 14-249]
Dang, Chau, MD
A Phase IA/IB Study of RO5509554 Alone and with Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-086]
D'Angelo, Sandra, MD
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat, MD, PhD
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie, PhD
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne, PhD
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
[Protocol 13-187]
Callahan, Margaret, MD, PhD
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
[Protocol 10-071]
Blinder, Victoria, MD
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine, MD, PhD
A Pilot Study of Acupuncture to Reduce Nerve Damage in Patients Receiving Paclitaxel for Breast Cancer
[Protocol 15-011]
Bao, Ting, MD
A Phase I Study of the Immune Activity and Safety of IMC-CS4 in Patients with Advanced Breast or Prostate Cancers
[Protocol 14-204]
Autio, Karen, MD
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079]
Ahles, Tim, PhD
Cognition in Older Breast Cancer Survivors: Influence of Treatment, Genetics, and Smoking History
[Protocol 14-071]
Ahles, Tim, PhD